<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00149266</url>
  </required_header>
  <id_info>
    <org_study_id>JCOG9502</org_study_id>
    <secondary_id>C000000122</secondary_id>
    <nct_id>NCT00149266</nct_id>
  </id_info>
  <brief_title>Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)</brief_title>
  <official_title>Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Japan Clinical Oncology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Labour and Welfare, Japan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Japan Clinical Oncology Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare left thoraco-abdominal approach with abdominal and transhiatal approach to cardia
      or subcardia cancer
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For gastric cancers with esophageal invasion (Siewert type II and III), thoraco-abdominal
      approach has shown better survival results than abdominal approach in retrospective analyses.
      However, patients having mediastinal nodal metastasis have poor prognosis and the benefit of
      thoraco-abdominal approach is still controversial. We evaluated the two approaches in a
      prospective randomized trial.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>July 1995</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>overall survival</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>relapse-free survival</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>operative morbidity and mortality</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
  </secondary_outcome>
  <enrollment type="Actual">167</enrollment>
  <condition>Gastric Neoplasm</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery: abdominal and transhiatal approach</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery: left thoraco-abdominal approach</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. histologically proven adenocarcinoma

          2. 75 years old or younger

          3. forced expiratory volume in one second ≥ 50 %

          4. arterial oxygen pressure in room air ≥ 70 mmHg

          5. clinically T2/T3/T4 with ≤3 cm esophageal invasion

          6. written consent

        Exclusion Criteria:

          1. Carcinoma in the remnant stomach

          2. Borrmann type 4 (linitis plastica)

          3. synchronous or metachronous malignancy in other organs except for cervical carcinoma
             in situ and colorectal focal cancer in adenoma

          4. history of left thoracotomy, or left pleural adhesion

          5. past history of myocardial infarction or positive results of exercise ECG

          6. liver cirrhosis, or chronic liver disease with indocyanine green test ≥15%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mitsuru Sasako, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Gastric Surgery Division, National Cancer Center Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Cancer Center Hospital</name>
      <address>
        <city>5-1-1 Tsukiji, Chuo-ku</city>
        <state>Tokyo</state>
        <zip>104-0045</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <link>
    <url>http://www.jcog.jp/</url>
  </link>
  <results_reference>
    <citation>Sasako M, Sano T, Yamamoto S, Sairenji M, Arai K, Kinoshita T, Nashimoto A, Hiratsuka M; Japan Clinical Oncology Group (JCOG9502). Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol. 2006 Aug;7(8):644-51.</citation>
    <PMID>16887481</PMID>
  </results_reference>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2005</study_first_submitted>
  <study_first_submitted_qc>September 7, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2005</study_first_posted>
  <last_update_submitted>February 2, 2009</last_update_submitted>
  <last_update_submitted_qc>February 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2009</last_update_posted>
  <keyword>stomach neoplasms</keyword>
  <keyword>lymph node resection</keyword>
  <keyword>cardia</keyword>
  <keyword>thoracotomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

